Get started
Author

Chao-Yi Wu

Pioglitazone Reduces Mortality and Adverse Events in Patients With Type 2 Diabetes and With Advanced Chronic Kidney Disease: National Cohort Study
2020 · Chieh-Li Yen, Chao-Yi Wu, et al. · Diabetes Care · 16
PDF
Manipulation of Metabolic Pathways and Its Consequences for Anti-Tumor Immunity: A Clinical Perspective
2020 · Huang-Yu Yang, Chao-Yi Wu, et al. · International Journal of Molecular Sciences · 16
Allergic diseases attributable to atopy in a population sample of Asian children
2021 · Chao-Yi Wu, Hsin-Yi Huang, et al. · Scientific Reports · 13
PDF
PPAR-γ agonist pioglitazone and the risks of malignancy among type2 diabetes mellitus patients
2024 · Lai-Chu See, Chao-Yi Wu, et al. · Acta Diabetologica · 7
Clinical features and lymphocyte immunophenotyping analysis in primary immunodeficiency patients with non-transplant lymphoproliferative disorders
2024 · Wen-I Lee, Jing-Long Huang, et al. · Clinical Immunology · 3
PDF
A proposed clinical tool to identify high-risk patients for monogenic lupus: a pilot study
2024 · Sulaiman M. Al-Mayouf, Djohra Hadef, et al. · Clinical and Experimental Rheumatology
PDF
Works count: 6
Citation count: 55
H-index: 4
I10-index: 3
Year
Topic
Type